Almouneer, an Egyptian healthtech startup, has raised $3.6 million in funding to attract top talent.
Global Ventures led the seed round, with participation from Wrightwood Investments, Proparco and Digital Africa through the Bridge Fund and other international funds.
Almouneer, founded by Noha Khater (CEO) and Rania Kadry (CTO), aims to transform healthcare for people with chronic diseases, including obesity and diabetes.
It’s no news that chronic diseases are the leading cause of death globally and are emerging global health threats.
Besides, by 2030, these chronic diseases will reportedly be the leading cause of death in sub-Saharan Africa, surpassing communicable, maternal, neonatal, and nutritional (CMNN) diseases.
Thus, before extending to treat patients with diabetes and other chronic illnesses with Kadry, Khater launched Almouneer in 2017 as a tech-enabled ophthalmology clinic. Following that, it transitioned from managing digital clinics to providing operational support to outside doctors and healthcare providers.
Almouneer uses extensive practice management software, which includes integrated financial systems, electronic health records, and booking systems.
Concurrent with this update was the release of its patient-focused app, DRU. Patients can upload their medical records, including critical data like blood pressure and blood sugar, to DRU.
Doctors can access and view the app's records, which include their most recent medical information and current prescriptions. The paid app also allows users to schedule teleconsultations, which enable them to speak with medical professionals over the phone or through chat.
Per the startup, DRU is the "first patient-centric, digitally-enabled lifestyle and diabetes management platform in the Middle East and Africa." Consequently, Almouneer will use the funds primarily to support the website's development and expansion.
In Q1 2024, it will launch the DRU app for doctors. Additionally, it will focus on expanding the provider ecosystem to encompass physicians, health coaches, nutritionists, and labs.
With Saudi Arabia, the United Arab Emirates, Nigeria, and Kenya as top priorities for the healthcare company in 2024, Almouneer is looking into potential product expansion into these countries.
Khater states that Almouneer wants to improve and broaden its range of services. The healthtech company intends to introduce dietary and treatment plans tailored to each patient in the coming months.
Patients can choose from individualised plans for obesity and uncontrolled diabetes that focus on lowering blood pressure and blood sugar levels.
Almouneer generates revenue through these customised plans and subscriptions. The healthtech intends to subtract a percentage from the fees it charges doctors for referrals in addition to including marketplace revenue. Patients will have access to vital supplies like blood sugar strips, glucose monitors, products for caring for their limbs, and diet plans through the market.
The healthtech startup provides healthcare services to more than 120,000 patients across nine hospitals and clinics in Egypt. Khater claims that during the past year, the healthtech has also reported doubling its business volumes and revenue figures.
The platform is essential to the prevention and treatment of diabetes, prediabetes, and obesity because it connects patients with doctors and a large network of healthcare providers through its app.